← Leaderboards
Liviu M Mirica
University Of California Berkeley
$3,318,370
Attributed
$3,318,370
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2007–23$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,318,370 · 5
By mechanism
RF1$1,783,700 · 1
R01$1,424,204 · 1
F32$71,666 · 1
P41$38,800 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Berkeley
Same institution · by research overlap
- Lisa Alvarez-Cohen$5,871,846
- Jack F Kirsch$2,393,965
- Kenneth N Raymond$12,285,592
- Judith Pollock Klinman$20,918,063
- Brenda Eskenazi$32,012,337
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBasePeptidesIonsS DiseaseNeurodegenerative DisordersSenile PlaquesAmyloidBrainCopperMolecularInvestigationMediatingMetalsTransition ElementsDesignAffectMissionMass Spectrum AnalysisEarly DiagnosisAmyloid DepositionImaging AgentAffinityDiagnosis
Grant awards (11)
Blood-Brain Barrier Permeable Multimodal Imaging Agents for Neurodegenerative Diseases$1,783,700
RF1 · FY2023 · AG · contact PI
Novel Bifunctional Chemical Agents as Theranostic Tools for Amyloid Diseases$266,612
R01 · FY2019 · GM · contact PI
NOVEL BIFUNCTIONAL CHEMICAL AGENTS AS THERANOSTIC TOOLS FOR AMYLOID DISEASES$209,095
R01 · FY2018 · GM · contact PI
Novel Bifunctional Chemical Agents as Theranostic Tools for Amyloid Diseases$79,247
R01 · FY2018 · GM · contact PI
NOVEL BIFUNCTIONAL CHEMICAL AGENTS AS THERANOSTIC TOOLS FOR AMYLOID DISEASES$289,750
R01 · FY2017 · GM · contact PI
NOVEL BIFUNCTIONAL CHEMICAL AGENTS AS THERANOSTIC TOOLS FOR AMYLOID DISEASES$289,750
R01 · FY2016 · GM · contact PI
NOVEL BIFUNCTIONAL CHEMICAL AGENTS AS THERANOSTIC TOOLS FOR AMYLOID DISEASES$289,750
R01 · FY2015 · GM · contact PI
SYNTHESIS OF NEW ORGANIC MOLECULES TO ADDRESS IMPORTANT METAL-MEDIATED PROCESSES$28,113
P41 · FY2011 · RR · contact PI
SYNTHESIS OF NEW ORGANIC MOLECULES TO ADDRESS IMPORTANT METAL-MEDIATED PROCESSES$10,687
P41 · FY2010 · RR · contact PI
Studies of ascorbate-dependent, non-heme iron enzyme ACC oxidase$22,020
F32 · FY2008 · GM · contact PI
Studies of ascorbate-dependent, non-heme iron enzyme ACC oxidase$49,646
F32 · FY2007 · GM · contact PI